Two Distinct Modes of ATR Activation Orchestrated by Rad17 and Nbs1  by Shiotani, Bunsyo et al.
Cell Reports
ArticleTwo Distinct Modes of ATR Activation
Orchestrated by Rad17 and Nbs1
Bunsyo Shiotani,1,3,* Hai Dang Nguyen,1 Pelle Ha˚kansson,1,4 Alexandre Mare´chal,1 Alice Tse,1 Hidetoshi Tahara,3
and Lee Zou1,2,*
1Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA
2Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
3Department of Cellular and Molecular Biology, Hiroshima University, Hiroshima 734-8553, Japan
4Present address: Department of Medical Biochemistry and Biophysics, Umea˚ University, SE-90187 Umea˚, Sweden
*Correspondence: bshiotan@hiroshima-u.ac.jp (B.S.), zou.lee@mgh.harvard.edu (L.Z.)
http://dx.doi.org/10.1016/j.celrep.2013.04.018SUMMARY
The ATM- and Rad3-related (ATR) kinase is a master
regulator of the DNA damage response, yet how ATR
is activated toward different substrates is still poorly
understood. Here, we show that ATR phosphorylates
Chk1 and RPA32 through distinct mechanisms at
replication-associated DNA double-stranded breaks
(DSBs). In contrast to the rapid phosphorylation of
Chk1, RPA32 is progressively phosphorylated by
ATR at Ser33 during DSB resection prior to the phos-
phorylation of Ser4/Ser8 by DNA-PKcs. Surprisingly,
despite its reliance on ATR and TopBP1, substantial
RPA32 Ser33 phosphorylation occurs in a Rad17-in-
dependent but Nbs1-dependent manner in vivo and
in vitro. Importantly, the role of Nbs1 in RPA32 phos-
phorylation can be separated from ATM activation
and DSB resection, and it is dependent upon the
interaction of Nbs1 with RPA. An Nbs1 mutant that
is unable to bind RPA fails to support proper recov-
ery of collapsed replication forks, suggesting that
the Nbs1-mediated mode of ATR activation is impor-
tant for the repair of replication-associated DSBs.
INTRODUCTION
The ability of cells to sense and signal DNA damage in their ge-
nomes is crucial for genomic stability. In human cells, the ataxia
telangiectasia mutated (ATM) and the ATM- and Rad3-related
(ATR) kinases are two master regulators of DNA damage
signaling (Ciccia and Elledge, 2010). ATM, ATR, and their related
DNA-dependent protein kinase catalytic subunit (DNA-PKcs)
belong to the PI3K-like kinase (PIKK) family. Whereas ATM and
DNA-PKcs are primarily activated by DNA double-stranded
breaks (DSBs), ATR responds to a broad spectrum of DNA dam-
age (Cimprich and Cortez, 2008; Flynn and Zou, 2011). Unlike
ATM and DNA-PKcs, ATR is essential for cell survival even in
the absence of extrinsic DNA damage, underscoring the critical
function of ATR in coping with intrinsic genomic stress (Barlow
et al., 2013; Brown and Baltimore, 2000; Murga et al., 2009;
Toledo et al., 2011). Although the DNA-damage specificitiesCand functions of ATM, ATR, and DNA-PKcs are clearly distinct,
how they distinguish different types of DNA damage and execute
their unique functions is still poorly understood. In particular, it is
largely unknown how ATR is activated by different types of DNA
damage and replication stress.
Studies in different organisms have revealed some of the key
principles of ATR activation. In response to DNA damage and
replication stress, the complex of ATR and its functional partner,
ATR-interacting protein (ATRIP), is recruited to sites of DNA
damage and stalled replication forks by replication protein A
(RPA)-coated single-stranded DNA (RPA-ssDNA) (Byun et al.,
2005; Costanzo et al., 2003; Zou and Elledge, 2003). The activa-
tion of ATR-ATRIP requires additional regulators, such as the
Rad17-RFC complex, the Rad9-Rad1-Hus1 (9-1-1) complex,
and TopBP1 (Kumagai et al., 2006; Lin et al., 2012; Navadgi-Patil
and Burgers, 2009; Zou et al., 2002). Independently of the
recruitment of ATR-ATRIP to RPA-ssDNA, the Rad17-RFC com-
plex recognizes the junctions of ssDNA and double-stranded
DNA (dsDNA) and loads 9-1-1 complexes onto dsDNA (Ellison
and Stillman, 2003; Zou et al., 2003). Through a process that is
still not fully understood, TopBP1 is recruited to damaged DNA
and interacts with Rad17, 9-1-1, and autophosphorylated ATR
(Cotta-Ramusino et al., 2011; Delacroix et al., 2007; Lee and
Dunphy, 2010; Lee et al., 2007; Liu et al., 2011; Wang et al.,
2011; Yan and Michael, 2009). The engagement of TopBP1
with ATR-ATRIP allows TopBP1 to stimulate the kinase activity
of ATR and to facilitate ATR to recognize its substrates (Kumagai
et al., 2006; Liu et al., 2011; Mordes et al., 2008). In this model of
ATR activation, ATR is activated by Rad17 and TopBP1 around
ssDNA/dsDNA junctions. Indeed, checkpoint kinase 1 (Chk1),
an effector kinase of ATR that is critical for the replication stress
response and cell-cycle arrest, is phosphorylated by ATR in
a Rad17-, TopBP1-, and ssDNA/dsDNA-junction-dependent
manner (Liu et al., 2006; MacDougall et al., 2007; Van et al.,
2010; Yamane et al., 2003; Zou et al., 2002). However, it is impor-
tant to note that although Chk1 phosphorylation has been widely
used as a surrogate for ATR activation, it remains unclear
whether Chk1 phosphorylation accurately evinces the active
mode of ATR in all situations.
In this study, we asked whether ATR is always activated by the
Rad17-TopBP1 circuitry after DNA damage occurs. In particular,
wewondered whether ATR is activated by Rad17 and TopBP1 at
extensively resected DSBs, such as those generated in S phaseell Reports 3, 1651–1662, May 30, 2013 ª2013 The Authors 1651
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at collapsed replication forks. When long ssDNA is generated at
DSBs by resection, a fraction of ATR could be recruited to the
RPA-ssDNA distal to ssDNA/dsDNA junctions, raising the ques-
tion as to whether and how this fraction of ATR is activated on
RPA-ssDNA. To address this question, we analyzed the activa-
tion of ATR by camptothecin (CPT), which induces replication-
associated DSBs that undergo rapid and efficient resection
(Avemann et al., 1988; Sartori et al., 2007). We found that ATR
is activated in two distinct modes toward Chk1 and RPA32. In
one mode, ATR phosphorylates Chk1 rapidly, whereas in the
other mode, ATR phosphorylates RPA32 Ser33 progressively
during resection. The activation of ATR toward RPA32 is driven
by resection and requires TopBP1. Surprisingly, Nbs1, a compo-
nent of the Mre1-Rad50-Nbs1 (MRN) complex (Carney et al.,
1998; Costanzo et al., 2001; Difilippantonio et al., 2005; Stracker
and Petrini, 2011), plays a more important role than Rad17 in the
phosphorylation of RPA32. The function of Nbs1 in RPA32 phos-
phorylation can be separated from ATM activation and DSB
resection, and is dependent upon a direct interaction between
Nbs1 and RPA. An Nbs1 mutant that is unable to bind RPA is
compromised in its ability to support the recovery of collapsed
replication forks. Together, these results suggest that Nbs1 me-
diates a TopBP1-dependent but Rad17-independent mode of
ATR activation on RPA-ssDNA, allowing ATR to phosphorylate
substrates such as RPA32 independently of ssDNA/dsDNA junc-
tions and promote repair of replication-associated DSBs.
RESULTS
ATR Phosphorylates Chk1 and RPA32 Ser33 via Distinct
Mechanisms
ATR is known to be activated by the replication-associated
DSBs induced by CPT (Avemann et al., 1988; Sartori et al.,
2007). Using VE-821, a specific ATR inhibitor (Reaper et al.,
2011), we confirmed that a number of ATR substrates, including
Chk1, Rad17, RPA32, and ATR itself, were phosphorylated in an
ATR-dependent manner after CPT treatment (Figure S1A). In
contrast to these ATR substrates, ATM and DNA-PKcs under-
went efficient autophosphorylation in the presence of VE-821
(Figure S1B). Furthermore, the phosphorylation of several ATM
and/or DNA-PKcs substrates, including Chk2, p53, and H2AX,
was not affected by VE-821 (Figure S1B). These results confirm
that VE-821 specifically inhibits ATR, but not ATM and DNA-
PKcs, in CPT-treated cells.
In response to CPT, RPA32 is phosphorylated atmultiple sites,
including Ser4/Ser8, Thr21, and Ser33 (Anantha et al., 2007;Figure 1. ATR-Mediated RPA32 Ser33 Phosphorylation in Response to
(A) U2OS cells were treated with 1 mMCPT in the presence or absence of 10 mMV
and the CPT-induced phosphorylation events were analyzed by western blot; *a
(B) Cells pretreated with 10 mM NU-7026 or DMSO for 1 hr were exposed to 1 mM
as in (A).
(C) Cells were treatedwith 1 mMCPT for 1 hr, ormock treated, in the absence or pr
was performed with specific antibodies. Representative images of cells are shown
foci are shown in the right panel. Error bars: SDs from three independent experim
(D) Cells were treated with 1 mM CPT for 2 hr, or mock treated, in the absence
quantified as in (C). Error bars: SDs from three independent experiments (n = 3).
(E) U2OS cells transfected with control or CtIP siRNAs were treated with 1 mM CP
See also Figure S1.
CBlock et al., 2004; Sartori et al., 2007). Using phosphospecific
antibodies, we found that RPA32 Ser33 was phosphorylated
within 15 min after CPT treatment, whereas RPA32 Ser4/Ser8
was phosphorylated at 60 min (Figure 1A). Furthermore, the
phosphorylation of RPA32 Ser33 was abolished by VE-821,
whereas RPA32 Ser4/Ser8 phosphorylation was only partially
reduced (Figure 1A). The phosphorylation of RPA32 Ser4/Ser8
was shown to be DNA-PKcs dependent (Anantha et al., 2007;
Liaw et al., 2011; Liu et al., 2012). Indeed, the CPT-induced
phosphorylation of RPA32 Ser4/Ser8 was abolished by the
DNA-PKcs inhibitor NU7026 (Figure 1B). In contrast, RPA32
Ser33 phosphorylation was not affected by NU7026 (Figure 1B).
Thus, compared with the phosphorylation of RPA32 Ser4/Ser8,
the phosphorylation of RPA32 Ser33 is a more direct and reliable
marker for ATR activation.
The phosphorylation of RPA32 has been linked to DSB
resection (Sartori et al., 2007). A recent study suggested that
ATR promotes resection in Xenopus extracts (Peterson et al.,
2013). Consistent with this finding, at 1 hr after CPT treatment,
the formation of RPA32 foci was reduced by VE-821 (Figure 1C).
Nevertheless, a significant fraction of VE-821-treated cells dis-
played RPA32 foci, suggesting that ATR is not essential for
resection (Figure 1C). Importantly, themajority of VE-821-treated
cells that displayed RPA32 foci were negative for phospho-
Ser33 foci, suggesting that ATR is required for RPA32 Ser33
phosphorylation after resection (Figure 1C). In contrast to VE-
821, the ATM inhibitor KU55933 drastically diminished the foci
of both RPA32 and phospho-Ser33 1 hr after CPT treatment
(Figure S1C). At 2 hr, KU55933-treated cells no longer displayed
a significant reduction in RPA32 foci and phospho-Ser33 foci
(Figure 1D), showing that inhibition of ATM delays resection tran-
siently. In KU55933-treated cells, RPA32 foci were always
colocalized with phospho-Ser33 foci (Figure 1D), suggesting
that ATM does not have a direct role in RPA32 Ser33 phos-
phorylation post resection. Consistent with RPA32 Ser33
phosphorylation being a specific marker of ATR activation, this
phosphorylation event was clearly detected in the ATM-deficient
AT cells and the DNA-PKcs-deficient M059J cells, even when
they were treated with NU7026 and KU55933, respectively (Fig-
ures S1D and S1E).
Having established RPA32 Ser33 phosphorylation as amarker
for CPT-induced ATR activation, we asked whether this
phosphorylation event is regulated in the same way as Chk1
phosphorylation. In response to CPT, Chk1 was rapidly phos-
phorylated at Ser345 in an ATR-dependent manner (Figure 1A).
In contrast to the phosphorylation of RPA32 Ser33, whichCPT-Induced DSBs
E-821 and collected at the indicated times. The levels of the indicated proteins
protein cross-reacting to the phospho-Ser33 antibody.
CPT in the presence or absence of 10 mM NU-7026. Extracts were analyzed
esence of VE-821. Immunofluorescence analysis of RPA32 and phospho-Ser33
in the left panel. The fractions of cells that displayed RPA32 or phospho-Ser33
ents (n = 3).
or presence of KU55933. Immunofluorescence analysis was performed and
T and collected at the indicated time points. Extracts were analyzed as in (A).
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Figure 2. RPA32 and Chk1 Are Phosphorylated by ATR through
Distinct Mechanisms
(A–C) U2OS cells transfected with control, TopBP1 (A), Rad17 (B), or Nbs1 (C)
siRNAs were treated with 1 mMCPT and collected at the indicated time points.
The levels of the indicated proteins and the CPT-induced phosphorylation
events were analyzed by western blot.
See also Figure S2.gradually accumulated during the first 60 min after CPT treat-
ment, Chk1 phosphorylation plateaued within 15min (Figure 1A).
Thus, Chk1 and RPA32 Ser33 are phosphorylated by ATR with
distinct kinetics. Consistent with the sequential phosphorylation
of RPA32 by ATR and DNA-PKcs (Anantha et al., 2007), the
phosphorylation of RPA32 Ser4/Ser8 by DNA-PKcs occurred
significantly later than Ser33 phosphorylation and Chk1 phos-
phorylation (Figure 1A; Kousholt et al., 2012).
The phosphorylation of RPA32 Ser4/Ser8 by DNA-PKcs re-
quires CtIP, which is critical for resection (Sartori et al., 2007).1654 Cell Reports 3, 1651–1662, May 30, 2013 ª2013 The AuthorsPrior to the abrupt phosphorylation of Ser4/Ser8, Ser33 was
gradually phosphorylated by ATR (Figure 1A), suggesting that
Ser33 phosphorylation may be the initial phosphorylation event
on RPA32 that is driven by resection. Indeed, knockdown of
CtIP with two independent small interfering RNAs (siRNAs) dras-
tically reduced the phosphorylation of RPA32 Ser33 during the
first 45 min after CPT treatment (Figure 1E). On the other hand,
consistent with a recent report (Kousholt et al., 2012), depletion
of CtIP did not significantly affect the phosphorylation of Chk1
during this early phase of the CPT response. Thus, in contrast
to the rapid phosphorylation of Chk1, the phosphorylation of
RPA32 Ser33 by ATR occurs progressively during resection.
Distinct Roles of Rad17 and Nbs1 in RPA
Phosphorylation
The distinct kinetics and resection dependency of Chk1 and
RPA32 phosphorylation prompted us to investigate whether
ATR is activated toward these two substrates in different ways.
To dissect the genetic requirements for RPA32 Ser33 phosphor-
ylation, we used siRNAs to knock down the upstream regulators
of the ATR pathway. Consistent with the effects of VE-821,
knockdown of ATR abolished the phosphorylation of both
Chk1 and RPA32 Ser33 (Figure S2A). Two independent siRNAs
targeting TopBP1, the key activator of ATR, also drastically
reduced the phosphorylation of Chk1 and RPA32 Ser33 (Fig-
ure 2A). Therefore, similar to Chk1 phosphorylation, RPA32
Ser33 phosphorylation requires both ATR and TopBP1.
TopBP1 and Rad17 function together in Chk1 phosphorylation
(Delacroix et al., 2007; Lee and Dunphy, 2010). As expected,
knockdown of Rad17 with two independent siRNAs significantly
reduced Chk1 phosphorylation (Figure 2B). Surprisingly, how-
ever, substantial RPA32 Ser33 phosphorylation was detected
in Rad17 knockdown cells (Figure 2B), suggesting the existence
of a Rad17-independent mechanism of RPA32 Ser33 phosphor-
ylation. TheMRNcomplex has been implicated in ATR regulation
and RPA phosphorylation (Jazayeri et al., 2006; Manthey et al.,
2007; Myers and Cortez, 2006; Olson et al., 2007a; Stiff et al.,
2005; Yoo et al., 2009; Zhong et al., 2005). Knockdown of
Nbs1 with two independent siRNAs clearly reduced RPA32
Ser33 phosphorylation without altering cell-cycle distribution
(Figures 2C and S2B). Consistent with Nbs1 knockdown, the
Nbs1-deficient NBN-ILB1 cells displayed much lower RPA32
Ser33 phosphorylation than the Nbs1-complemented cells (Fig-
ure S2C). Compared with Rad17 knockdown, Nbs1 knockdown
reduced RPA32 Ser33 phosphorylation to a greater extent.
When both Rad17 and Nbs1 were knocked down, RPA32
Ser33 phosphorylation was further reduced (Figure S2D), sug-
gesting that Rad17 and Nbs1 function in parallel to activate
ATR toward RPA32 Ser33. Interestingly, although Nbs1 knock-
down clearly reduced RPA32 Ser33 phosphorylation, its effects
on Chk1 phosphorylation were modest (Figure 2C). Thus, in
contrast to Rad17, Nbs1 plays a more important role in RPA
phosphorylation than in Chk1 phosphorylation.
Nbs1 Mediates RPA32 Phosphorylation Independently
of Rad17 and ssDNA/dsDNA Junctions
The MRN complex regulates ATM activation and DSB resection
(Symington and Gautier, 2011; Uziel et al., 2003). Furthermore,
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Figure 3. Nbs1 Regulates RPA32 Phosphor-
ylation Independently of ATMActivation and
DSB Resection
(A) Nuclear extracts were prepared from HeLa
cells transfected with TopBP1 siRNA or mock
transfected. A 6 kb dsDNA fragment was resected
with T7 exonuclease or exonuclease III as
described in the Experimental Procedures. Re-
sected or unresected dsDNA was added to cell
extracts, and the resected-dsDNA-induced
phosphorylation of RPA32 Ser33 was analyzed
with phosphospecific antibody.
(B) The resected-dsDNA-induced phosphorylation
of RPA32 Ser33 was analyzed in extracts of CtIP
knockdown cells and control cells as in (A).
(C) The resected-dsDNA-induced phosphorylation
of RPA32 Ser33 was analyzed in extracts of Rad17
knockdown cells and control cells as in (A).
(D) The resected-dsDNA-induced phosphorylation
of RPA32 Ser33 was analyzed in extracts of Nbs1
knockdown cells and control cells as in (A).the MRN complex is implicated in the removal of TopI from CPT-
induced DSBs (Sacho andMaizels, 2011). To determine whether
Nbs1 regulates RPA32 phosphorylation directly or indirectly, we
analyzed the function of Nbs1 in RPA32 phosphorylation using
an in vitro assay that we recently developed (Shiotani and Zou,
2009). In this assay, linear dsDNA is resected by T7 exonuclease
or exonuclease III to generate ssDNA overhangs, and subse-
quently is added to HeLa cell nuclear extracts to activate ATR
(Shiotani and Zou, 2011). Using this assay, we have shown
that RPA32 Ser33 is phosphorylated in an ATR-dependent
manner. Since both ATM and DNA-PKcs are inhibited in ex-
tracts, and dsDNA is already resected before it is added to ex-
tracts, this assay provides a unique opportunity to test whether
Nbs1 has an ATM-, resection-, and end-processing-indepen-
dent function in RPA32 phosphorylation.
Consistent with its dependency on TopBP1 in cells, RPA32
Ser33 phosphorylation was not induced by resected dsDNA in
extracts derived from TopBP1 knockdown cells (Figure 3A).
In contrast, RPA32 Ser33 phosphorylation occurred efficiently
in extracts from CtIP knockdown cells, confirming that the role
of MRN-CtIP in DSB resection is bypassed by the use of prere-
sected dsDNA in this assay (Figure 3B). Also consistent with the
observation in cells, the phosphorylation of RPA32 Ser33 in ex-
tracts was only modestly reduced by Rad17 depletion (Fig-
ure 3C). Strikingly, even in this resection-independent in vitro
assay, Nbs1 was clearly required for RPA32 Ser33 phosphoryla-
tion (Figure 3D). These results reveal a postresection function of
Nbs1 in RPA32 phosphorylation.
Since substantial RPA32 Ser33 phosphorylation occurred
independently of Rad17 in vivo and in vitro, we asked if this phos-
phorylation event is absolutely dependent upon ssDNA/dsDNA
junctions. In nuclear extracts, ssDNA alone was sufficient to
induce RPA32 Ser33 phosphorylation in a length-dependent
manner (Figure 4A). We noted that unlike resected dsDNA,
ssDNA did not induce a mobility shift of RPA32 in protein gels.
The reason for this difference is currently unknown. Importantly,Cthe ssDNA-induced RPA32 Ser33 phosphorylation was depen-
dent upon ATR, TopBP1, and Nbs1 (Figures 4B–4D), suggesting
that a process driven by ssDNA lengthening and mediated by
Nbs1 and TopBP1 is able to activate ATR toward RPA indepen-
dently of ssDNA/dsDNA junctions.
Nbs1 Targets the MRN Complex to RPA-ssDNA
We next asked how Nbs1 executes its postresection function in
ATR activation. The MRN complex interacts with RPA (Oakley
et al., 2009; Olson et al., 2007b). Consistent with previous
studies, we found that in extracts, Mre11, Rad50, and Nbs1 all
bound to ssDNA in an RPA-dependent manner (Figure 5A). The
RPA complex containing the RPA70 t-11 mutant, whose N-ter-
minal oligonucleotide/oligosaccharide-binding (OB) fold was
disrupted by point mutations, was unable to recruit MRN to
ssDNA (Figure 5B). Furthermore, purified MRN complex bound
to ssDNA in an RPA-dependent manner, showing that MRN as-
sociates with RPA-ssDNA directly (Figure 5C). Even in the
absence of Mre11 and Rad50, purified Nbs1 bound to ssDNA
in an RPA-dependent manner, suggesting a direct interaction
between Nbs1 and RPA-ssDNA (Figure 5D).
To determine whether the recruitment of MRN to RPA-ssDNA
is dependent on Nbs1, we generated extracts from Nbs1 knock-
down cells. Consistent with previous studies, loss of Nbs1 did
not affect the levels of Mre11 and Rad50 (Figure 5E; Stewart
et al., 1999). However, in extracts of Nbs1 knockdown cells,
neither Mre11 nor Rad50 bound to RPA-ssDNA efficiently (Fig-
ure 5E). In contrast to Mre11 and Rad50, ATRIP still associated
with RPA-ssDNA efficiently in the absence of Nbs1 (Figure 5E).
Together, these results suggest that Nbs1 targets theMRN com-
plex to RPA-ssDNA.
Nbs1 Binds RPA-ssDNA via a Previously
Uncharacterized Domain
To determine whether the interaction between Nbs1 and RPA-
ssDNA is important for the phosphorylation of RPA32 Ser33 byell Reports 3, 1651–1662, May 30, 2013 ª2013 The Authors 1655
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(A) ssDNA of the indicated lengths was added to
nuclear extracts, and the ssDNA-induced phos-
phorylation of RPA32 Ser33 was analyzed with
phosphospecific antibody.
(B) The ssDNA-induced phosphorylation of RPA32
Ser33 was analyzed in extracts of ATR knockdown
cells and control cells as in (A).
(C) The ssDNA-induced phosphorylation of RPA32
Ser33 was analyzed in extracts of TopBP1
knockdown cells and control cells as in (A).
(D) The ssDNA-induced phosphorylation of RPA32
Ser33 was analyzed in extracts of Nbs1 knock-
down cells and control cells as in (A).ATR, we sought to map the RPA-ssDNA-interacting domain of
Nbs1. We expressed a set of myc-tagged Nbs1 fragments in
cells and tested them for binding to biotinylated ssDNA coated
with RPA (Figures 6A, S3A, and S3B). An Nbs1 fragment contain-
ing the N-terminal FHA and BRCT domains (Np38) was unable to
interact with RPA-ssDNA (Figure S3A). On the other hand, two
Nbs1 fragments lacking the FHA and BRCT domains (Cp49
and Cp38) retained the ability to interact with RPA-ssDNA (Fig-
ure S3B). Moreover, an Nbs1 fragment lacking the C-terminal
ATM and Mre11 binding domains (Np75) still bound to RPA-
ssDNA (Figure S3A). Thus, the RPA-ssDNA-interacting domain
of Nbs1 is distinct from its known functional domains.
Through testing the binding of additional Nbs1 fragments to
RPA-ssDNA (Figures S3A and S3B), we found that all of the
Nbs1 fragments that were able to bind RPA-ssDNA encom-
passed amino acids 536–567 (Figure 6A). Alignment of the se-
quences of Nbs1 from different species revealed that a stretch
of charged amino acids in this region is conserved in higher ver-
tebrates (Figure 6B). To pinpoint the residues that are critical for
RPA-ssDNA binding, we mutated the conserved residues KKR,
DD, and EDE to EEG, AA, and AAA in full-length Nbs1, respec-
tively (Figure 6B; Nbs1KKR, Nbs1DD, and Nbs1EDE). Only the
Nbs1EDE mutant, and not the Nbs1KKR and Nbs1DD mutants,
lost the ability to bind RPA-ssDNA (Figure 6C). The Nbs1EDE
mutant still bound to Mre11 efficiently (Figure 6D), suggesting
that loss of the EDEmotif of Nbs1 specifically disrupts its binding
to RPA-ssDNA.
The Recognition of RPA-ssDNA by Nbs1 Is Important for
RPA32 Ser33 Phosphorylation and Recovery of
Collapsed Forks
To determine whether the binding of Nbs1 to RPA-ssDNA is
important for RPA32 Ser33 phosphorylation, we first tested the
Nbs1EDE mutant in vitro. We expressed siRNA-resistant wild-
type myc-Nbs1 (myc-Nbs1WT) and myc-Nbs1EDE in cells that1656 Cell Reports 3, 1651–1662, May 30, 2013 ª2013 The Authorswere depleted of endogenous Nbs1 by
siRNA and prepared extracts from these
cells. In the myc-Nbs1WT-containing ex-
tracts, resected dsDNA induced RPA32
Ser33 phosphorylation efficiently (Fig-
ure 7A). In contrast, RPA32 Ser33
phosphorylation was poorly induced byresected dsDNA in extracts containingmyc-Nbs1EDE (Figure 7A),
suggesting that the ability of Nbs1 to recognize RPA-ssDNA is
important for its postresection function in RPA32 Ser33 phos-
phorylation in vitro.
Next, we tested whether the Nbs1EDE mutant is able to support
RPA32 Ser33 phosphorylation in cells. We generated stable cell
lines in which siRNA-resistant myc-Nbs1WT or myc-Nbs1EDE
could be inducibly expressed. Upon induction of myc-Nbs1WT in
Nbs1knockdowncells,RPA32Ser33phosphorylationwasclearly
inducedbyCPT (Figure7B, lanes3and4). In contrast, the levelsof
RPA32 Ser33 phosphorylationwere not increased by CPT in cells
expressing the myc-Nbs1EDE mutant (Figure 7B, lanes 7 and 8).
Thus,consistentwithour invitroexperiments, theNbs1EDEmutant
also fails to support RPA32 Ser33 phosphorylation in cells.
Finally, we sought to determine whether the recognition of
RPA-ssDNA by Nbs1 is important for the DNA damage
response. Because CPT induces replication-associated DSBs,
we focused on the recovery of collapsed replication forks. We
synchronized cells in S phase with thymidine and released
them into CPT-containing media. As expected, gH2AX foci
were induced in cells regardless of whether endogenous Nbs1
was replaced bymyc-Nbs1WT or myc-Nbs1EDE (Figure 7C). After
the myc-Nbs1WT-expressing cells were released from CPT,
gH2AX foci were largely gone in 24 hr (Figure 7C), indicating
the recovery of collapsed forks. In contrast, a significant fraction
of the myc-Nbs1EDE-expressing cells retained gH2AX foci 24 hr
after the release fromCPT (Figure 7C), suggesting that the recov-
ery of collapsed forks was compromised. These results establish
a functional link between Nbs1-mediated ATR activation and the
repair of replication-associated DSBs.
DISCUSSION
Many investigators have studied the activation of ATR using
Chk1 phosphorylation as a readout. Both in vivo and in vitro
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(A) Biotinylated 70-nucleotide ssDNA (5 pmole)
was coated with increasing amounts of purified
RPA (0, 5, 10, and 20 pmole) and then incubated in
cell extracts. The proteins bound to RPA-ssDNA
were retrieved by streptavidin-coated beads and
analyzed by western blot using the indicated
antibodies. All components of the Mre11-Rad50-
Nbs1 complex bound to ssDNA in an RPA-
dependent manner.
(B) Biotinylated ssDNA was coated with either WT
RPA or the RPA t-11 mutant complex purified from
E. coli. The binding of Rad50 and Mre11 to RPA-
ssDNA was tested as in (A).
(C) Biotinylated ssDNA coated with RPA was
incubated with purified MRN complex. The MRN
components bound to RPA-ssDNA were analyzed
by western blot.
(D) Binding of purified Nbs1 to RPA-ssDNA was
tested as in (C).
(E) Extracts were prepared from cells transfected
with control or Nbs1-2 siRNA. Biotinylated ssDNA
coated with RPA was incubated in the extracts,
and the proteins bound to RPA-ssDNA were
analyzed by western blot using the indicated an-
tibodies.experiments have suggested that Rad17 and TopBP1 are two
key regulators of the activation of ATR toward Chk1 (Cimprich
and Cortez, 2008; Flynn and Zou, 2011). In the current model
of ATR activation, both RPA-ssDNA and ssDNA/dsDNA junc-
tions are critical determinants of Chk1 phosphorylation (Mac-
Dougall et al., 2007). Whereas RPA-ssDNA presents a platform
for ATR-ATRIP recruitment, the Rad17-RFC complex and 9-1-
1 complexes are localized to ssDNA/dsDNA junctions. The co-
localization of ATR-ATRIP, Rad17, 9-1-1, and TopBP1 around
ssDNA/dsDNA junctions may create a protein-DNA assembly
that allows TopBP1 to activate the ATR-ATRIP kinase complex
and enable it to recognize its downstream substrates. This
mechanism of ATR activation toward Chk1 is consistent withCell Reports 3, 1651–166the fact that ssDNA is not sufficient to
trigger checkpoint signaling through
Chk1 (Guo and Dunphy, 2000; MacDou-
gall et al., 2007).
Although ssDNA and ssDNA/dsDNA
junctions are commonly induced by
DNA damage and replication stress, the
relative abundance of these two DNA
structures may vary in different contexts.
For example, at replication forks stalled
by aphidicolin, an increased number of
primers and ssDNA/dsDNA junctions
may be generated, which would enhance
the activation of ATR toward Chk1 (Van
et al., 2010). On the other hand, when
DSBs undergo extensive resection in S
phase, long stretches of ssDNA may be
generated without increasing the numberof ssDNA/dsDNA junctions. We found that RPA32 Ser33 is pro-
gressively phosphorylated by ATR during the resection of CPT-
induced DSBs. Although it is an ATR-mediated event, RPA32
Ser33 phosphorylation is regulated differently from Chk1
activation. In addition to its delayed kinetics and greater depen-
dency on resection, RPA32 Ser33 phosphorylation is more
dependent on Nbs1 but less dependent on Rad17 compared
with Chk1 phosphorylation. Furthermore, unlike Chk1 phosphor-
ylation, RPA32 Ser33 phosphorylation can occur on ssDNA in
a length-dependent manner independently of ssDNA/dsDNA
junctions. These findings suggest that, in a resection-driven
manner, Nbs1 mediates a distinct mode of ATR activation
toward RPA32.2, May 30, 2013 ª2013 The Authors 1657
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Figure 6. Mapping the RPA-ssDNA-Interacting Domain of Nbs1
(A) Schematic of the Nbs1 fragments used in this study and their ability to bind
RPA-ssDNA.
(B) The RPA-ssDNA-binding domain of human Nbs1 is aligned to the corre-
sponding regions in the Nbs1 of other higher vertebrates. The conserved
charged amino acids are highlighted in colors.
(C) The conserved charged amino acids in the RPA-ssDNA-binding domain of
Nbs1 were mutated in myc-tagged, full-length Nbs1 (KKR to EEG, DD to AA,
and EDE to AAA). These Nbs1 mutants were transiently expressed in 293T
cells, and their ability to bind RPA-ssDNA was tested in cell extracts using
biotinylated ssDNA coated with RPA. WT Nbs1 and an Nbs1 mutant lacking
the Mre11- and ATM-binding domains (Np75) were also tested as controls.
(D) Myc-tagged, full-length Nbs1 (WT) and its mutant derivatives (KKR, DD,
EDE, and Np75) were transiently expressed in 293T cells. The myc-tagged
Nbs1 proteins were immunoprecipitated with myc antibody, and the copre-
cipitated Mre11 was analyzed by western blot using Mre11 antibody.
See also Figure S3.How do Rad17 and Nbs1 regulate the activation of ATR during
resection? As resection is initiated at DSBs and ssDNA/dsDNA
junctions are generated, the Rad17-RFC complex recognizes
these junctions and loads 9-1-1 complexes onto dsDNA (Fig-1658 Cell Reports 3, 1651–1662, May 30, 2013 ª2013 The Authorsure 7D). This Rad17- and ssDNA/dsDNA-junction-mediated pro-
cess promotes ATR activation andChk1 phosphorylation around
the ssDNA/dsDNA junctions. In addition, a fraction of RPA adja-
cent to ssDNA/dsDNA junctions is phosphorylated by ATR in a
Rad17-dependent manner during this early phase of resection.
As resection continues, the ssDNA is gradually lengthened,
and increasing amounts of RPA and ATR-ATRIP are placed on
the ssDNA distal to ssDNA/dsDNA junctions (Figure 7D). In the
late phase of resection, a fraction of RPA and ATR-ATRIP on
ssDNA becomes ‘‘out of reach’’ for the Rad17 and 9-1-1 com-
plexes at ssDNA/dsDNA junctions. In this situation, the MRN
complex may directly recognize RPA-ssDNA via Nbs1, and acti-
vate ATR-ATRIP by recruiting TopBP1 (Yoo et al., 2009). Consis-
tent with this model, substantial RPA32 Ser33 phosphorylation is
driven by resection and is dependent upon both Nbs1 and
TopBP1 in vivo and in vitro. Furthermore, the direct interaction
between Nbs1 and RPA-ssDNA is needed for efficient RPA32
Ser33 phosphorylation both in vivo and in vitro. Since the
Nbs1-mediated mode of ATR activation is independent of
Rad17, which interacts with Claspin to promote Chk1 activation
(Wang et al., 2006), this mode of ATR activation is specifically
directed to RPA but not Chk1.
When and where does Nbs1 activate ATR in cells? In laser mi-
croirradiated cells, a fraction of Nbs1 precisely colocalizes with
RPA in the ssDNA subcompartments at DSBs (Bekker-Jensen
et al., 2006). In the context of DNA replication, Mre11 partially co-
localizes with PCNA during S phase (Maser et al., 2001).
Although RPA32 Ser33 phosphorylation is rapidly induced by
CPT, it does not occur robustly in hydroxyurea (HU)-treated cells
until DSBs become detectable in these cells (Figures 1A and
S1F; Sakasai et al., 2006). This observation, together with the de-
pendency of RPA32 Ser33 phosphorylation on resection, sug-
gests that RPA32 Ser33 phosphorylation occurs primarily at
replication-associated DSBs. Indeed, in previous studies, the
phosphorylation of RPA32 was implicated in the progression
and repair of stressed replication forks (Liu et al., 2012; Shi
et al., 2010; Vassin et al., 2009). We found that when the interac-
tion between Nbs1 and RPA-ssDNAwas disrupted, the recovery
of collapsed replication forks was compromised (Figure 7C).
These findings suggest that the Nbs1-mediated mode of ATR
activation may be particularly important for the repair of replica-
tion-associated DSBs. Consistent with this idea, the MRN
complex was shown to colocalize with RPA at collapsed forks
(Manthey et al., 2007). Furthermore, the MRN complex is
required for preventing accumulation of DSBs during replication
(Costanzo et al., 2001). In addition to themechanism that we pro-
pose, recent studies suggested that Mre11 degrades stalled
replication forks in the absence of BRCA1/2 and Fanconi anemia
proteins, and promotes ATR activation via a nuclease-depen-
dent mechanism at stalled forks (Lee and Dunphy, 2013;
Schlacher et al., 2011, 2012). Another recent study showed
that the Xenopus MRN complex recognizes the ssDNA/dsDNA
junctions in synthetic DNA templates and recruits TopBP1 to
DNA (Duursma et al., 2013).We note that the EDEmotif of human
Nbs1 is not conserved in XenopusNbs1, suggesting that the role
of MRN in ATR activation may have expanded during evolution.
The MRN complex may regulate the ATR response and protect
replication forks through multiple mechanisms.
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Figure 7. The Interaction of Nbs1 andRPA Is
Required for Nbs1-Mediated RPA32 Phos-
phorylation and Recovery of Collapsed
Replication Forks
(A) U2OS-derivative cell lines were established to
express myc-tagged Nbs1WT and Nbs1EDE
conditionally. As indicated, cells were treated with
1 mg/ml doxycycline (Dox) to induce myc-tagged
Nbs1 proteins, and transfected with siNbs1-2 to
knock down endogenous Nbs1. Nuclear extracts
were prepared from cells, and the ability of re-
sected dsDNA to induce RPA32 Ser33 phos-
phorylation was analyzed with phosphospecific
antibody.
(B) Myc-tagged Nbs1WT and Nbs1EDE were used
to replace endogenous Nbs1 as in (A). Cells were
synchronized in S phase as described in Experi-
mental Procedures and subsequently treated with
CPT (1 mM) for 45 min or mock treated. The levels
of the indicated proteins and the phosphorylation
of RPA32 Ser33 were analyzed by western blot.
(C) Myc-tagged Nbs1WT and Nbs1EDE were used
to replace endogenous Nbs1 as in (A). Cells were
synchronized in S phase, treated with CPT (1 mM)
for 1 hr or mock treated, and then released into
CPT-free medium. After 24 hr, cells were immu-
nostained with antibody to gH2AX and the frac-
tions of cells with gH2AX foci were quantified.
Error bars: SDs from three independent experi-
ments (n = 3).
(D) A model that depicts the two distinct modes of
ATR activation at resected DSBs.It is important to note that although the phosphorylation of
RPA32 Ser33 is a marker for Nbs1-mediated ATR activation,
ATR may have additional substrates when it is activated in this
mode. Many of the known or putative substrates of ATR,
including a number of DNA repair proteins, interact with RPA
andmay accumulate onRPA-ssDNA during resection (Matsuoka
et al., 2007). The Nbs1-mediated mode of ATR activation may
contribute to the phosphorylation of these ATR substrates and
to DNA repair, particularly during the late phase of the DNA dam-
age response. Together, Rad17 and Nbs1 may orchestrate the
phosphorylation of two distinct sets of ATR substrates in two
sequential phases of the DNA damage response. Whereas
Rad17 may promote DNA damage signaling, cell-cycle arrest,
and the early events of DNA repair through Chk1 phosphoryla-
tion, Nbs1 may promote the late events of DNA repair through
progressive phosphorylation of ATR substrates on RPA-ssDNA.
The coordination of these two distinct mechanisms of ATR acti-
vation may be important for the full function of ATR in the DNA
damage response.Cell Reports 3, 1651–166EXPERIMENTAL PROCEDURES
Cell Culture and Drug Treatment
HeLa, U2OS, and 293T cells were cultured in Dul-
becco’s modified Eagle’s medium (DMEM) sup-
plemented with 10% fetal bovine serum (FBS).
NBS-ILB1 cells were cultured in DMEM supple-
mented with 15% FBS. NBS1-ILB1 cells stably ex-
pressing the full-length Nbs1 transgene were
maintained in the same medium containing500 mg/ml G418. For RNAi, cells were transfected with 40 nM siRNA using
RNAi MAX transfection reagent (Invitrogen). The sequences of the siRNAs
used in this study are listed in the Extended Experimental Procedures. Plasmid
transfection of 293T cells was performed with Lipofectamine 2000 (Invitrogen)
and the transfected cells were analyzed after 48 hr. U2OS derivative cell lines
stably expressingmyc-Nbs1 ormutants were cultured in DMEMwith 10%FBS
and 100 mg/mL Zeocin (Invitrogen). Expression of myc-Nbs1 was induced with
1 mg/mL doxycycline (Sigma). To synchronize cells in S phase, cells were
treated with 2.5 mM thymidine (Sigma) for 20 hr, washed thoroughly with
PBS, and released into thymidine-freemedium for 3 hr. To assess the recovery
of collapsed replication forks, synchronized S phase cells were treated with
CPT for 1 hr and then released into CPT-free medium. Kinase inhibitors VE-
821, KU55933, and NU7026 were used at 10 mM. CPT was used at 1 mM.
Antibodies
The phosphospecific antibodies to ATR pT1989 were previously described
(Liu et al., 2011). We obtained ATR, Nbs1, Mre11, Rad50, TopBP1, phos-
pho-Rad17 (Ser645), and phospho-RPA32 (Ser33 and Ser4/Ser8) antibodies
from Bethyl; Rad17 and Chk1 antibodies from Santa Cruz; phospho-Chk1
(Ser345), phospho-Chk2 (Thr68), and phospho-p53 (Ser15) antibodies from
Cell Signaling; phospho-H2AX (Ser139) antibody from Millipore; phospho-
ATM (Ser1981) antibody from Epitomics; RPA32 antibody from Thermo2, May 30, 2013 ª2013 The Authors 1659
Scientific; and Myc antibody from Medical & Biological Laboratories. Phos-
pho-DNA-PKcs (Ser2056) and CtIP antibodies were kindly provided by
Drs. B. Chen and R. Baer, respectively.
Extract-Based ATR Activation Assay
An extract-based ATR activation assay was performed as described previ-
ously (Shiotani and Zou, 2011). To analyze ssDNA-induced ATR activation, nu-
clear extracts were pretreated with 10 mMof KU-55933 and NU7026 for 15min
on ice to inhibit ATM and DNA-PKcs, and supplemented with the reaction
buffer (buffer R), which brought the final buffer compositions to 10 mMHEPES
(pH 7.6), 50 mM KCl, 0.1 mM MgCl2, 1 mM phenylmethanesulfonylfluoride,
0.5 mM dithiothreitol, 1 mM ATP, 10 mg/ml creatine kinase, and 5 mM phos-
phocreatine. ssDNA of various lengths was incubated in the extracts for
30 min at 37C. The sequences of the DNA oligonucleotides used in this study
are listed in the Extended Experimental Procedures.
RPA-ssDNA Binding Assay
Biotinylated ssDNA (50TGCAGCTGGCACGACAGGTTTTAATGAATCGGC
CA-ACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCT-biotin-30) was
attached to streptavidin-coated magnetic beads in binding buffer (10 mM
Tris-HCl [pH 7.5], 100 mM NaCl, 10% glycerol, 0.01% NP-40, and 10 mg/ml
bovine serum albumin) followed by incubation with or without purified RPA
at room temperature for 30 min. To analyze the binding of various proteins
to RPA-ssDNA, we incubated RPA-ssDNA with purified MRN, Nbs1, or cell ly-
sates in the binding buffer. To map the RPA-ssDNA-interacting domain of
Nbs1, we used lysates prepared from cells expressing various myc-Nbs1 mu-
tants. After a 30min incubation at room temperature, beadswere retrieved and
washed twice with the binding buffer. The proteins bound to beads were de-
natured in the SDS sample buffer, separated on SDS-PAGE, and analyzed
by western blot. Recombinant RPA complex was purified from Escherichia
coli as previously described (Henricksen et al., 1994). The MRN complex
and Nbs1 were purified from insect cells infected with baculoviruses express-
ing Mre11, Rad50, and Nbs1 (Paull and Gellert, 1999).SUPPLEMENTAL INFORMATION
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